105 related articles for article (PubMed ID: 13678381)
1. Multidrug resistance in hematological malignancy.
Hirose M; Hosoi E; Hamano S; Jalili A
J Med Invest; 2003 Aug; 50(3-4):126-35. PubMed ID: 13678381
[TBL] [Abstract][Full Text] [Related]
2. Drug resistance in multiple myeloma.
Sonneveld P; Lokhorst HM; Vossebeld P
Semin Hematol; 1997 Oct; 34(4 Suppl 5):34-9. PubMed ID: 9408959
[TBL] [Abstract][Full Text] [Related]
3. CD34+ cells from acute myeloid leukemia, myelodysplastic syndromes, and normal bone marrow display different apoptosis and drug resistance-associated phenotypes.
Suárez L; Vidriales MB; García-Laraña J; Sanz G; Moreno MJ; López A; Barrena S; Martínez R; Tormo M; Palomera L; Lavilla E; López-Berges MC; de Santiago M; de Equiza ME; Miguel JF; Orfao A
Clin Cancer Res; 2004 Nov; 10(22):7599-606. PubMed ID: 15569991
[TBL] [Abstract][Full Text] [Related]
4. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
[TBL] [Abstract][Full Text] [Related]
5. Multidrug resistance-related phenotype and apoptosis-related protein expression in ovarian serous carcinomas.
Yakirevich E; Sabo E; Naroditsky I; Sova Y; Lavie O; Resnick MB
Gynecol Oncol; 2006 Jan; 100(1):152-9. PubMed ID: 16198399
[TBL] [Abstract][Full Text] [Related]
6. Expression of multidrug resistance-associated proteins in rhabdomyosarcomas before and after chemotherapy: the relationship between lung resistance-related protein (LRP) and differentiation.
Klunder JW; Komdeur R; Van Der Graaf WT; De Bont EJ; Hoekstra HJ; Van Den Berg E; Molenaar WM
Hum Pathol; 2003 Feb; 34(2):150-5. PubMed ID: 12612883
[TBL] [Abstract][Full Text] [Related]
7. [Expression of lung resistance protein and multidrug resistance-associated protein in naive childhood acute leukemia and their clinical significance].
Zhang JB; Sun Y; Dong J; Liu LX; Ning F
Ai Zheng; 2005 Aug; 24(8):1015-7. PubMed ID: 16086885
[TBL] [Abstract][Full Text] [Related]
8. Expression of multidrug resistance-related markers in primary neuroblastoma.
Lu QJ; Dong F; Zhang JH; Li XH; Ma Y; Jiang WG
Chin Med J (Engl); 2004 Sep; 117(9):1358-63. PubMed ID: 15377429
[TBL] [Abstract][Full Text] [Related]
9. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells.
Molnar J; Mucsi I; Nacsa J; Hevér A; Gyémánt N; Ugocsai K; Hegyes P; Kiessig S; Gaal D; Lage H; Varga A
Anticancer Res; 2004; 24(2B):865-71. PubMed ID: 15161039
[TBL] [Abstract][Full Text] [Related]
10. Fractionated irradiation can induce functionally relevant multidrug resistance gene and protein expression in human tumor cell lines.
Bottke D; Koychev D; Busse A; Heufelder K; Wiegel T; Thiel E; Hinkelbein W; Keilholz U
Radiat Res; 2008 Jul; 170(1):41-8. PubMed ID: 18582150
[TBL] [Abstract][Full Text] [Related]
11. Expression of multidrug resistance-related proteins p-glycoprotein, glutathione-s-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
Hepatogastroenterology; 2008; 55(86-87):1530-6. PubMed ID: 19102336
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of drug resistance in hematologic malignancies.
Dalton WS
Semin Hematol; 1997 Oct; 34(4 Suppl 5):3-8. PubMed ID: 9408955
[TBL] [Abstract][Full Text] [Related]
13. Multidrug resistance in gastric cancer: recent research advances and ongoing therapeutic challenges.
Zhang D; Fan D
Expert Rev Anticancer Ther; 2007 Oct; 7(10):1369-78. PubMed ID: 17944563
[TBL] [Abstract][Full Text] [Related]
14. Differences in anti-apoptotic and multidrug resistance phenotypes in elderly and young acute myeloid leukemia patients are related to the maturation of blast cells.
Suárez L; Vidriales MB; Moreno MJ; López A; García-Laraña J; Pérez-López C; Tormo M; Lavilla E; López-Berges MC; de Santiago M; San Miguel JF; Orfao A;
Haematologica; 2005 Jan; 90(1):54-9. PubMed ID: 15642669
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in P-glycoprotein-mediated multidrug resistance reversal mechanisms.
Li X; Li JP; Yuan HY; Gao X; Qu XJ; Xu WF; Tang W
Methods Find Exp Clin Pharmacol; 2007 Nov; 29(9):607-17. PubMed ID: 18193112
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy resistance in acute myeloid leukaemia.
Sonneveld P; List AF
Best Pract Res Clin Haematol; 2001 Mar; 14(1):211-33. PubMed ID: 11355932
[TBL] [Abstract][Full Text] [Related]
17. [Synergistic effect of bromocriptine combining tumor necrosis factor-alpha on reversing multidrug resistance in a nude mouse model of liver neoplasm].
Ding L; Chen XP; Zhang ZW; Wang H; Cao B; Wang ZH; Li CL
Zhonghua Wai Ke Za Zhi; 2005 Oct; 43(19):1248-53. PubMed ID: 16271222
[TBL] [Abstract][Full Text] [Related]
18. Expression of lung resistance-related protein in transitional cell carcinoma of bladder.
Zhu Y; Kong C; Zeng Y; Sun Z; Gao H
Urology; 2004 Apr; 63(4):694-8. PubMed ID: 15072883
[TBL] [Abstract][Full Text] [Related]
19. Biology of multiple drug resistance in acute leukemia.
Nørgaard JM; Hokland P
Int J Hematol; 2000 Oct; 72(3):290-7. PubMed ID: 11185984
[TBL] [Abstract][Full Text] [Related]
20. Cellular mechanisms of multidrug resistance of tumor cells.
Stavrovskaya AA
Biochemistry (Mosc); 2000 Jan; 65(1):95-106. PubMed ID: 10702644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]